Expression of the early lymphocyte activation antigen CD69, a C‐type lectin, is regulated by mRNA degradation associated with AU‐rich sequence motifs

CD69 is the earliest inducible cell surface glycoprotein acquired during lymphoid activation both in vitro and in vivo under physiological conditions and inflammation. This molecule is involved in lymphocyte proliferation, and functions as a signal‐transmitting receptor in T and B lymphocytes, NK cells and platelets. Molecular cloning of CD69 cDNA revealed that this antigen is a type‐II integral membrane protein with a C‐type lectin domain in the extracellular region. The expression time course of CD69 mRNA has previously been reported to be transient, peaking around 3 h after induction in T lymphocytes, and declining to nearly resting levels by 8 h. We describe herein studies on the stability of the CD69 mRNA in phorbol ester‐activated T lymphocytes. The level of CD69 mRNA in these cells declined rapidly with a half‐life of less than 60 min. This finding is consistent with the presence of several AU‐rich sequence motifs in the 3′ untranslated region (3′UTR), which have been implicated in the selective destabilization of short‐lived mRNA of mammalian cytokines, and proto‐oncogenes. We have therefore introduced a fragment of the 3′UTR of the human CD69 cDNA, which contains the AU‐rich sequence motifs, into the 3′UTR of the rabbit β‐globin gene. This inserted sequence causes the otherwise stable β‐globin mRNA to become unstable in vivo. A similar destabilizing effect is observed when the 51‐nucleotide AU sequence from the mRNA of the human cytokine granulocyte/macrophage colony‐stimulating factor is used as a positive control. Furthermore, the introduction of 194‐bp fragment from the CD69 3′UTR containing most of the AU‐rich motifs was sufficient to induce the destabilizing effect. We propose that the selective degradation pathway involved in the regulation of the expression of cytokines and proto‐oncogenes is implicated in the rapid degradation of CD69 mRNA in activated T lymphocytes. This pathway may constitute a general mechanism to regulate the expression of inducible molecules involved in inflammatory processes.

[1]  H. Gaugitsch,et al.  A novel transiently expressed, integral membrane protein linked to cell activation. Molecular cloning via the rapid degradation signal AUUUA. , 1992, The Journal of biological chemistry.

[2]  J. Malter,et al.  Association of heterogeneous nuclear ribonucleoprotein A1 and C proteins with reiterated AUUUA sequences. , 1993, The Journal of biological chemistry.

[3]  F. Sánchez‐Madrid,et al.  Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis. , 1991, The Journal of clinical investigation.

[4]  G. Crabtree Contingent genetic regulatory events in T lymphocyte activation. , 1989, Science.

[5]  F. Sánchez‐Madrid,et al.  Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes , 1988, The Journal of experimental medicine.

[6]  T. Nakayama,et al.  CD69 cell surface expression identifies developing thymocytes which audition for T cell antigen receptor-mediated positive selection. , 1993, International immunology.

[7]  R. Testi,et al.  T cell activation via Leu-23 (CD69). , 1989, Journal of immunology.

[8]  R Parker,et al.  Mechanisms of mRNA degradation in eukaryotes. , 1994, Trends in biochemical sciences.

[9]  J. Diaz,et al.  Evolutionary conservation of the AU-rich 3' untranslated region of messenger RNA. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[10]  G. Crabtree,et al.  Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link. , 1990, Annual review of immunology.

[11]  B. Nadel,et al.  Vλ‐Jλ rearrangements are restricted within a V‐J‐C recombination unit in the mouse , 1991 .

[12]  W. Swat,et al.  CD 69 expression during selection and maturation of CD4+8+ thymocytes , 1993, European journal of immunology.

[13]  J. Stephens,et al.  Tumor necrosis factor alpha-induced glucose transporter (GLUT-1) mRNA stabilization in 3T3-L1 preadipocytes. Regulation by the adenosine-uridine binding factor. , 1992, The Journal of biological chemistry.

[14]  V. Winn,et al.  cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R. Swerlick,et al.  Alternatively processed human E-selectin transcripts linked to chronic expression of E-selectin in vivo. , 1994, Journal of immunology.

[16]  A. Sanfridson,et al.  Enhanced stability of interleukin-2 mRNA in MLA 144 cells. Possible role of cytoplasmic AU-rich sequence-binding proteins. , 1994, The Journal of biological chemistry.

[17]  F. Sánchez‐Madrid,et al.  Tumor necrosis factor‐α production induced in T lymphocytes through the AIM/CD69 activation pathway , 1992 .

[18]  T. Miyata,et al.  Regulation of human tissue factor expression by mRNA turnover. , 1993, The Journal of biological chemistry.

[19]  F. Sánchez‐Madrid,et al.  Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors , 1993, The Journal of experimental medicine.

[20]  F. Sánchez‐Madrid,et al.  Expression of a novel activation antigen on intrahepatic CD8+ T lymphocytes in viral chronic active hepatitis. , 1990, Gastroenterology.

[21]  F. Sánchez‐Madrid,et al.  Adhesion molecules from the LFA‐1/ICAM‐1, 3 and VLA‐4/VCAM‐1 pathways on T lymphocytes and vascular endothelium in Graves' and Hashimoto's thyroid glands , 1994, European journal of immunology.

[22]  J. Alberta,et al.  Identification of an activity that interacts with the 3'-untranslated region of c-myc mRNA and the role of its target sequence in mediating rapid mRNA degradation. , 1994, The Journal of biological chemistry.

[23]  I. Verma,et al.  Regulated mRNA stability. , 1990, Annual review of genetics.

[24]  J. Redondo,et al.  Expression and function of AIM, an activation inducer molecule of human lymphocytes, is dependent on the activation of protein kinase C , 1989, European journal of immunology.

[25]  G. Shaw,et al.  A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation , 1986, Cell.

[26]  N. Proudfoot,et al.  Direct demonstration of termination signals for RNA polymerase II from the sea urchin H2A histone gene. , 1989, Nucleic acids research.

[27]  N. Proudfoot Transcriptional interference and termination between duplicated α-globin gene constructs suggests a novel mechanism for gene regulation , 1986, Nature.

[28]  M. Strauss,et al.  Expression cloning of the early activation antigen CD69, a type II integral membrane protein with a C-type lectin domain. , 1993, Journal of immunology.

[29]  S. Ziegler,et al.  Molecular characterization of the early activation antigen CD69: A type II membrane glycoprotein related to a family of natural killer cell activation antigens , 1993, European journal of immunology.

[30]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[31]  R. Testi,et al.  CD69 is expressed on platelets and mediates platelet activation and aggregation , 1990, The Journal of experimental medicine.

[32]  R. Flavell,et al.  DNA sequences necessary for transcription of the rabbit β-globin gene in vivo , 1982, Nature.

[33]  L. Lanier,et al.  Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen , 1988, The Journal of experimental medicine.

[34]  R. Testi,et al.  Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors , 1994, The Journal of experimental medicine.

[35]  F. Sánchez‐Madrid,et al.  Structure‐function relationship and immunochemical mapping of external and intracellular antigenic sites on the lymphocyte activation inducer molecule, AIM/CD69 , 1991, European journal of immunology.